
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ
Year End December 30 2024 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -66.755 | -52.9 | -53.29 | -31.367 | -41.901 | -32.698 | -13.351 |
Return on Equity (%) | 200.404 | -92.985 | -68.29 | -57.466 | -103.463 | -83.651 | -37.082 |
Return on Invested Capital (%) | -70.29 | -70.094 | -75.157 | -188.26 | -461.286 | -33.688 | -12.295 |
Operating Margin (%) | N/A | N/A | N/A | -346.75 | -163.624 | -79.045 | -21.55 |
Net Profit Margin (%) | N/A | N/A | N/A | -438.855 | -176.047 | -87.681 | -26.104 |
Book Value Per Share | 9.722 | 5.768 | 5.779 | 3.318 | 2.248 | -0.091 | -0.504 |
Earnings Per Share | -3.406 | -2.325 | -3.468 | -2.746 | -3.671 | -3.506 | -1.832 |
Cash Per Share | 10.201 | 0.53 | 4.772 | 1.025 | 0.758 | 6.142 | 4.635 |
Working Capital Per Share | 9.722 | 4.703 | 7.317 | 4.054 | 3.396 | 6.446 | 5.546 |
Operating Profit Per Share | N/A | N/A | N/A | 0.564 | 1.838 | 3.221 | 5.809 |
EBIT Per Share | -3.406 | -2.324 | -3.468 | -2.745 | -3.844 | -3.484 | -1.81 |
EBITDA Per Share | -3.406 | -2.324 | -3.468 | -2.745 | -3.844 | -3.484 | -1.81 |
Free Cash Flow Per Share | -3.406 | -2.319 | -3.471 | -2.144 | -3.751 | -3.307 | -1.887 |
Year End December 30 2024 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 5.09M | 22.6M | 29.78M | 30.58M | 36.96M | N/A | N/A |
Year End December 30 2024 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
Shares Outstanding | 36.81M | 36.96M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -81.293 | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | -95.354 | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 2.13B |
Price to Earnings Ratio | -24.2 |
Price to Sales Ratio | 6.32 |
Price to Cash Ratio | 9.56 |
Price to Book Ratio | 9.43 |
Dividend Yield | - |
Shares Outstanding | 49.01M |
Average Volume (1 week) | 583.5k |
Average Volume (1 Month) | 564.54k |
52 Week Change | 51.92% |
52 Week High | 54.234 |
52 Week Low | 23.14 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.